Indefinite Delivery Contract HSHQDC12C00051
Award Date
9/27/12
Last Date to Order
5/31/16
Federal Agency
Office of Procurement Operations
Awardee
Bavarian Nordic A / S
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Pricing Type
Cost Plus Fixed Fee
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Defense Health Agency awarded a single-award indefinite delivery contract to Bavarian Nordic A/S with a potential value of $245,070 to provide endpoint titer analysis services in support of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) through September 2028. A $45,000 firm fixed price delivery order against this contract tasks Bavarian Nordic to perform endpoint titer analysis services for USAMRIID from September 2023 through September 2024 in Denmark....
This indefinite delivery contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the German biotechnology company IDT Biologika GMBH. The $80,000,000 multiple award contract is for manufacturing and characterization services for vaccines and other biologics for infectious disease research and pandemic preparedness efforts. Task orders issued under the contract include influenza virus human challenge...
This Indefinite Delivery Contract was awarded by the Biomedical Advanced Research and Development Authority (BARDA), which is part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). The single-award contract, valued up to $45,000,000, was granted to the Netherlands-based research organization Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek (TNO). The contract's purpose is to maintain...
This indefinite delivery contract, awarded by the Joint Program Executive Office for Chemical and Biological Defense (part of the U.S. Department of the Army), aims to complete the advanced development of a monoclonal antibody drug product, G03-52-01, to regulatory approval for prophylaxis against aerosolized botulinum neurotoxin A and B serotypes. The prime contractor, Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.), is a technology-focused biomanufacturing...
This Indefinite Delivery Contract (IDC) with a ceiling value of $9,901,350.00 was awarded by the Centers for Disease Control and Prevention (CDC) to Bavarian Nordic, Inc. for the procurement of adult vaccines. The period of performance runs from July 1, 2025 to June 30, 2026. Bavarian Nordic, Inc. is a biotechnology company that focuses on developing and manufacturing cancer immunotherapies and vaccines for infectious diseases. The company holds multiple Federal Supply Schedule contracts,...
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs (VA) to Bavarian Nordic, Inc., is for the procurement of drugs, pharmaceuticals, and hematology-related products over a 5-year period with a $10 million ceiling value. Bavarian Nordic, a biotechnology company focused on developing cancer immunotherapies and vaccines, holds multiple Federal Supply Schedule contracts that allow federal agencies to efficiently procure pharmaceuticals, drugs, and vaccines as needed....
This indefinite delivery contract, awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Mapp Biopharmaceutical, Inc., a for-profit Subchapter S Corporation, is focused on the advanced research and development of medical countermeasures against chemical, biological, radiological, nuclear, and pandemic influenza threats. The contract, valued at up to $50,097,495, has a period of performance through June 30, 2026 and is a single award with...
This Other Transaction IDV was awarded on June 13, 2020 by the Defense Advanced Research Projects Agency to Modernatx, Inc. The potential value is $7,852,706. The agreement is to perform optimization work culminating in a Phase I clinical trial of an mRNA construct that encodes a lead SARS-CoV-2 antibody candidate in support of COVID-19 response efforts. Specifically, the prime contractor will develop an optimized mRNA-encoded antibody against the novel SARS-CoV-2 virus. Work will include mRNA...
This indefinite delivery contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services, to the Lovelace Biomedical Research Institute. The $45,000,000 single-award contract runs through July 31, 2025 and is for the development of animal models to evaluate medical countermeasures for chemical, biological, radiological, and nuclear (CBRN) threats, pandemic influenza, and emerging...
The federal contract IDV award is an Other Transaction (OT) agreement with a ceiling value of $32,432,424.00, awarded by the Joint PEO Chemical and Biological Defense (JPEO-CBD) to Battelle Memorial Institute, a large non-profit research and development organization. The purpose of this OT agreement is to provide candidates for medical countermeasures against the alphavirus, a category of viruses. Battelle Memorial Institute, with over 20,000 global employees, is an experienced federal...